Acetic acid, benzyl(1-cyclopropylethyl)amine
CAS : 1252180-29-2
Ref. 3D-CAC18029
50mg | 272,00 € | ||
500mg | 1.015,00 € |
Informations sur le produit
Acetic acid, benzyl(1-cyclopropylethyl)amine (ABE) is a new drug candidate for the treatment of type II diabetes. ABE has been shown to inhibit the growth of Candida glabrata at a concentration of 0.5 mM and to be effective against c. albicans at a concentration of 1 mM. ABE also exhibits an optimum concentration in the range of 0.25-0.5 M, which can be achieved by diluting it with 50% ethanol or water for injection and then filtering the solution before administration, as well as through pretreatment with cerevisiae or Saccharomyces cerevisiae (a yeast). ABE has been shown to have hypoglycemic effects in both yeast and mouse models of type II diabetes, although it has not yet been tested on humans.
Propriétés chimiques
Question d’ordre technique sur : 3D-CAC18029 Acetic acid, benzyl(1-cyclopropylethyl)amine
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages